These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 29180288)
61. Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration. Banks WA; During MJ; Niehoff ML J Pharmacol Exp Ther; 2004 May; 309(2):469-75. PubMed ID: 14724226 [TBL] [Abstract][Full Text] [Related]
62. Discovery of unique and ENM- specific pathophysiologic pathways: Comparison of the translocation of inhaled iridium nanoparticles from nasal epithelium versus alveolar epithelium towards the brain of rats. Kreyling WG Toxicol Appl Pharmacol; 2016 May; 299():41-6. PubMed ID: 26861261 [TBL] [Abstract][Full Text] [Related]
63. Deposition of aluminum in brain tissues of rats exposed to inhalation of aluminum acetylacetonate. Zatta P; Favarato M; Nicolini M Neuroreport; 1993 Sep; 4(9):1119-22. PubMed ID: 8219037 [TBL] [Abstract][Full Text] [Related]
64. Direct transport of VEGF from the nasal cavity to brain. Yang JP; Liu HJ; Cheng SM; Wang ZL; Cheng X; Yu HX; Liu XF Neurosci Lett; 2009 Jan; 449(2):108-11. PubMed ID: 18996442 [TBL] [Abstract][Full Text] [Related]
65. Bioavailability and intestinal absorption of aluminum in rats: effects of aluminum compounds and some dietary constituents. Cunat L; Lanhers MC; Joyeux M; Burnel D Biol Trace Elem Res; 2000 Jul; 76(1):31-55. PubMed ID: 10999429 [TBL] [Abstract][Full Text] [Related]
66. Intranasal delivery of nerve growth factor to protect the central nervous system against acute cerebral infarction. Zhao HM; Liu XF; Mao XW; Chen CF Chin Med Sci J; 2004 Dec; 19(4):257-61. PubMed ID: 15669182 [TBL] [Abstract][Full Text] [Related]
67. Inhibition of rat brain phosphatidylinositol-specific phospholipase C by aluminum: regional differences, interactions with aluminum salts, and mechanisms. Nostrandt AC; Shafer TJ; Mundy WR; Padilla S Toxicol Appl Pharmacol; 1996 Jan; 136(1):118-25. PubMed ID: 8560464 [TBL] [Abstract][Full Text] [Related]
68. Distribution of α-asarone in brain following three different routes of administration in rats. Lu J; Fu T; Qian Y; Zhang Q; Zhu H; Pan L; Guo L; Zhang M Eur J Pharm Sci; 2014 Oct; 63():63-70. PubMed ID: 25008114 [TBL] [Abstract][Full Text] [Related]
69. Poly(ethylene oxide/propylene oxide) copolymer thermo-reversible gelling system for the enhancement of intranasal zidovudine delivery to the brain. Ved PM; Kim K Int J Pharm; 2011 Jun; 411(1-2):1-9. PubMed ID: 21356294 [TBL] [Abstract][Full Text] [Related]
70. Luteinizing hormone-releasing hormone (LHRH) in rat olfactory systems. Witkin JW; Silverman AJ J Comp Neurol; 1983 Aug; 218(4):426-32. PubMed ID: 6352748 [TBL] [Abstract][Full Text] [Related]
71. Accumulation of Cd(II) in the CNS depending on the route of administration: intraperitoneal, intratracheal, or intranasal. Evans J; Hastings L Fundam Appl Toxicol; 1992 Aug; 19(2):275-8. PubMed ID: 1516785 [TBL] [Abstract][Full Text] [Related]
72. [Studies on effects of aluminum compounds on aluminum contents in serum and brain of mice with high performance capillary electrophoresis]. Wu YH; Zhou ZM; Wang YL Zhongguo Zhong Yao Za Zhi; 2004 Jan; 29(1):59-61. PubMed ID: 15709385 [TBL] [Abstract][Full Text] [Related]
73. Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system. Dhuria SV; Hanson LR; Frey WH J Pharmacol Exp Ther; 2009 Jan; 328(1):312-20. PubMed ID: 18945930 [TBL] [Abstract][Full Text] [Related]
74. Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain. Zhang Q; Jiang X; Jiang W; Lu W; Su L; Shi Z Int J Pharm; 2004 May; 275(1-2):85-96. PubMed ID: 15081140 [TBL] [Abstract][Full Text] [Related]
75. Delivery of interferon-beta to the monkey nervous system following intranasal administration. Thorne RG; Hanson LR; Ross TM; Tung D; Frey WH Neuroscience; 2008 Mar; 152(3):785-97. PubMed ID: 18304744 [TBL] [Abstract][Full Text] [Related]
76. Delivery of 125I-cobrotoxin after intranasal administration to the brain: a microdialysis study in freely moving rats. Li F; Feng J; Cheng Q; Zhu W; Jin Y Int J Pharm; 2007 Jan; 328(2):161-7. PubMed ID: 17049426 [TBL] [Abstract][Full Text] [Related]
77. [Preparation of huperzine A nasal in situ gel and evaluation of its brain targeting following intranasal administration]. Tao T; Zhao Y; Yue P; Dong WX; Chen QH Yao Xue Xue Bao; 2006 Nov; 41(11):1104-10. PubMed ID: 17262956 [TBL] [Abstract][Full Text] [Related]
78. Enhanced brain targeting efficiency of intranasally administered plasmid DNA: an alternative route for brain gene therapy. Han IK; Kim MY; Byun HM; Hwang TS; Kim JM; Hwang KW; Park TG; Jung WW; Chun T; Jeong GJ; Oh YK J Mol Med (Berl); 2007 Jan; 85(1):75-83. PubMed ID: 17089096 [TBL] [Abstract][Full Text] [Related]
79. The olfactory route for cerebrospinal fluid drainage into the peripheral lymphatic system. Walter BA; Valera VA; Takahashi S; Ushiki T Neuropathol Appl Neurobiol; 2006 Aug; 32(4):388-96. PubMed ID: 16866984 [TBL] [Abstract][Full Text] [Related]
80. [An acute experimental study on the combinations of aluminum and fluorine in various ratios]. Li D; Xiao B; Dong Q; Li S; Zhan C Hua Xi Yi Ke Da Xue Xue Bao; 1990 Sep; 21(4):440-3. PubMed ID: 2094648 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]